Amphotericin B colloidal dispersion: an improved antifungal therapy
- 1 April 2001
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 47 (2-3) , 149-163
- https://doi.org/10.1016/s0169-409x(01)00104-1
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Treatment of systemic fungal infections: Recent progress and current problemsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin BAntimicrobial Agents and Chemotherapy, 1988
- Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.Journal of Clinical Oncology, 1987
- Amphotericin B-Induced Oxidative Damage and Killing of Candida albicansThe Journal of Infectious Diseases, 1986
- Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary StudyThe Journal of Infectious Diseases, 1985
- Antifungal Agents Useful in Therapy of Systemic Fungal InfectionsAnnual Review of Pharmacology and Toxicology, 1983
- Amphotericin B in Liposomes: A Novel Therapy for Histoplasmosis1American Review of Respiratory Disease, 1982
- Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterolsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1982
- Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomesJournal of Antimicrobial Chemotherapy, 1981
- On the anatomy of amphotericin B-cholesterol pores in lipid bilayer membranesKidney International, 1973